<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100911">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02019459</url>
  </required_header>
  <id_info>
    <org_study_id>5U54DA031659-03</org_study_id>
    <nct_id>NCT02019459</nct_id>
  </id_info>
  <brief_title>Very Low Nicotine Cigarettes in Smokers With Schizophrenia</brief_title>
  <official_title>Very Low Nicotine Cigarettes in Smokers With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Smokers with schizophrenia (SWS) infrequently attempt and attain sustained smoking
      abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study
      will examine whether reducing the nicotine content of cigarettes to non-addicting levels is
      a viable method of reducing smoking in this population. Smokers will be randomized to one of
      two experimental conditions: 1) very low nicotine content (VLNC) cigarettes or 2) normal
      nicotine content (NNC) cigarettes. Participants will be assessed for patterns of tobacco
      use, biomarkers of exposure, subjective responses (e.g., satisfaction, craving, withdrawal
      symptoms), psychiatric symptoms, cognitive performance, smoking cue reactivity and smoking
      topography.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Number of cigarettes smoked per day</measure>
    <time_frame>End of 6 week intervention</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>0.8 mg nicotine with 10.5 mg tar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SPECTRUM Cigarette: 0.8 (±0.15) mg with 9 (±1.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.07 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SPECTRUM Cigarette: 0.07 mg (± 0.02) nicotine with 9 mg (± 1.5) tar</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Very low nicotine content cigarettes</intervention_name>
    <arm_group_label>0.07 mg nicotine with 9 mg tar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard nicotine content cigarettes</intervention_name>
    <arm_group_label>0.8 mg nicotine with 10.5 mg tar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70

          -  Schizophrenia or schizoaffective disorder

          -  Smoke an average of at least 10 cigarettes per day for at least 1 year

          -  Breath CO levels &gt;8 ppm (if ≤ 8 ppm, then NicAlert Strip &gt; 2)

        Exclusion Criteria:

          -  Pregnant or nursing

          -  Seeking treatment for smoking

          -  Medical contraindications
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Tidey, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Tidey, Ph.D.</last_name>
    <phone>(401) 863-6418</phone>
    <email>jennifer_tidey@brown.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jennifer Tidey, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Jennifer Tidey</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Nicotine polacrilex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
